Home › Funds › Bellevue Group AG › ELV
Bellevue Group AG position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Bellevue Group AG reported holding 56,449 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$21.8M, representing 0.46% of its reported portfolio and ranking #49 among its reported holdings. Bellevue Group AG has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Bellevue Group AG's ELV position evolved
Bellevue Group AG first disclosed a stake in ELV in Q3 2023 at 173,887 shares (US$75.7M). Across 12 filings, Bellevue Group AG increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 56,449 shares valued at US$21.8M — an increase of 3,931 shares quarter over quarter.. Notable position changes include a 38% trim in Q4 2023 (shares rose 10% over the following quarter), a 57% trim in Q4 2024 (shares rose 18% over the following quarter), a 105% increase in Q2 2025 (shares fell 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 173.89K | $75.71M | New |
| Q4 2023 | 107.79K | $50.83M | Reduce |
| Q1 2024 | 98.61K | $51.13M | Reduce |
| Q2 2024 | 101.55K | $55.03M | Add |
| Q3 2024 | 89.33K | $46.45M | Reduce |
| Q4 2024 | 38.34K | $14.14M | Reduce |
| Q1 2025 | 40.06K | $17.42M | Add |
| Q2 2025 | 82.05K | $31.92M | Add |
| Q3 2025 | 104.97K | $33.92M | Add |
| Q4 2025 | 69.64K | $24.41M | Reduce |
| Q1 2026 | 52.52K | $15.37M | Reduce |
| Q2 2026 | 56.45K | $21.83M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.25B · Q2 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- Artisan Partners Limited Partnership 4.58M sh · $1.77B · Q2 2026
- First Eagle Investment Management 4.19M sh · $1.62B · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.02M sh · $779.73M · Q2 2026
More on Bellevue Group AG
FAQ
How long has Bellevue Group AG held ELV?
Bellevue Group AG has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Bellevue Group AG's current position in ELV?
As of Q2 2026, Bellevue Group AG holds 56.45K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $21.83M, representing 0.46% of its reported portfolio and ranking #49.
Has Bellevue Group AG been buying or selling ELV?
In the latest 13F filing (Q2 2026), Bellevue Group AG increased its position in ELV.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.